1
!
"# $! "
%
"
&' ( $)
) 1378 -
1383 (
-1
-2 3
!"
(DKA) :
! " # $ %$ &
'(
( .
$* +, -
. ( / +0 1 & 2 , 345 # $1 ( 67 ! 8 (
9 5 : ; 22 + <
/ = >
" ? @#
.
- / : +,
A 0
"BC
$6#
&
; # $D 8 (
5 : E"=D
8 ( F / DKA
1378 - 1383
/ = >
2 1$C $ $
. L @ 60
= D
$M#
1 & 2 , N OP 8 (
( 67 !
%$
$
1$C $ #
2 .
; Q 8 (
; A ; " 8 !
?$#
SPSS =1
$ 8 ! 9 > 0 =@0
2 1$C . / / 6# : 74
/
±11 63 / 26 F . 60
% 40
%
# $
. 8$ < 8 ( / 6#
9 /
±3 2 / 7
. &
# 7# / , 2 3
/ 18
% " Q . W+*
E" / $ + " , )
50 (%
. 75
%
# " ( 8$ <
[
\0 50
%
" ; ( = D .
pH/ 6#
# $"
1 /
±0 1 / 7 .
$0 # ] (
25
% 8 3 < # A &
(UTI)
54
%
>C ] (
<
23
%
" ; ( 7
DKA .
@ / 3
/ 3
%
= D ^ ( .
=
$ %$
5
% .
+, - / _ # Q 0 :
$6# # ?
; P$ # 3 < 2"!
-DKA
E
8 ` 1
3`
>P \a
"
- b ! 2 /
# 0
=
%$ L "
$ ( '(
.
L # : 1 [ [
< >C ] (
) ( * + ,- ./ ,- ,0$
)
! 15 3 2 3 5 1387 (
: : 6 / 10 / 1385
? @%A :
21 / 3 / 1386 B C
: 24 / 7 / 1386
1
# [F c< ; 2<
" ` N P E"=D ? > ; 67# & > & >P ; $C 7#
-
/ = #
d ! : / = -
> P
-
>
2 -
<D f 2 86165
- 34137
/A>0 : 3356696 - 0281
$ # : 3326033 - 0281 E # $ E, <D [email protected] :
2
" ` N P E"=D ? > ; 67# & > & >P ; $C -
/ = #
3
" ` N P E"=D ? > ; 67# & > & g"=D -
/ = #
# $
2 8 2
N $ h0 P
Ni5
, :O $ &g 2 <( 3( j :0
&
#
D 2 . + Q F
1997 124
; " !$ >
$ ' D d 2
" ` # `Q
(WHO)
F 2025 300
$A# >
. + Q $ 2
>
!$ $A#
; "
) 1 (.
L # 1
8 k Ol7
A D
E #m $M#
l ! n# !
"
. o0 k : $ 95
%
L # 5 : D A
1
#! 8 m 8 (
DR3-DR4
2"
) 2 .(
*
"
1
` E"=D 8 k 0
L # 1
;
"
@ '( &/ , <# : ; $ (
$ h0 3
# +*
"
[
? N
$
" %$ p # 0 .
k L "
14
100000
$A#
"
) 3 .(
q l70
< >C$] ( d $ -
#
$( 2r$(
g N $( M0 /
9> s 0 # 0
" @ = # $6 g , [
k5:
9 / $ + "
<
+
; # A ; 22
, N +, -
1 # .$O - Q
/ , <#
> / $ + "
2#
) 4 .(
20
% o
$( M0 / , 2 >:
&
r
# "
) 5 .(
A / $ + "
#
# A # 2D /
8
30 - 50
%
;
"
.
+ < 9 $ & $0 &9E, .$O t 9 " ; 22
! , : :> E
"
L # # 0 2
3(
" ; . 8 (
$ h0 p 2
3< ,
N ( $
(
# "
&
& ( 4 $ E 0 2#
&/ 2D
u >
; 22 A, ; #$ C 8 (
&
g 0 .$O
(
2" 8 $ ; 22 < 9 2# 0
) 4 .(
A
v D =1 ;
8 (
$ A# 8 >Q
; 0 / , <# u # = 8 / , <#
$w 2"
&
' =1 p L "
; "
. +, -
; A L " DCCT
22
;
v D / ( N o =0 # $ + " $ $ +
$
" 8 >Q
#
&
; " b =C
) 6 .(
=#m 0 D ; $ ( / , <# : " #
( ' =1 9E0 & C >C 2# (
/
& (
F = 0
" (
.
@ 8 $
&
:
8 $* C >C 8 / , <#
.
< >C$] (
' =1 >
, 0
= >C 8 : )
=#m x# >C
= , #m E >C (
s 2 .$O " 9 l Q
! .
#
8 ! M 5 9 ' =1 @
8 (
! y$r
$r 1
? <Q P 9 0 / $ 2
#
^ :
( .
; $ ( / , <# = '(
/ ! 9E0 ' =1 (
$@2 " (
' =1
= , ] ,
! y$r 8 ( " !
"
pH .
g m , = 1
9 :0 ( # ? <Q
"
#
z2P N 2 $E s 0 {]
# $C [ / N
/ 1 N 2 $E $ P|
&
^ g , (
) 7 .(
& 1 N + 2 =6 Q 9 "
$ E, O0
, / / , <# < >C$] ( & (
2 9 $
; 22 @ 8 )
7 - 15 .(
+, - / +0 . ( $*
5 # $1
4
& 2 , 3 9
+ <
1 &; 22
= ( 67 ! 8 (
%$
$
" ? @#
.
%&
' $()
A 0 +, - /
"BC
$6#
; # $D &
8 ( 0
5 :
(DKA)
<
$
; " 8
/ = >
8 `, /
1378 - 1383
2 1$C $ $
(DKA) .
N
Blood Glucose >250 mg/dL
&
pH<7.3
Arterial
&
Serum bicarbonate<18 meq/l
" 1$C $M# 8 # .
= D $ > 9>
&DKA
b$ BD ? & # A " # N )
/ , <# } =0 (
&
$ ql7 # 9>
) 8 & $0 A# & $ # $0 C &
( 3 <o0 8 2
"
.
* @
&
= D g $ 7 N
Q 0 DKA
$M# ( = D / # > 1 1$C
"
.
N 5a `20 $1 /
F = D 9
9 > 0 =@0 1$C $
.
=
$ %$
N
" W $+0 ( = D +0 $ %$ +0 3 <o0 .
OP N 8 $1 ) / 9 :
&
# E 9 &{2Q (
OP 2 , N )
= D $ > 9> 9 : &DKA
L
@ > E" &
& +Q $
& 5 N 8$ < 8 ( +0
=
$ %$
( Q ?$1 g } $a 8 !
N 5a BP
"
.
$ OP 2 , N )
+* 9 :
8 " ( (
( 67 ! )
pH =
&
=
& P 2
=
P $> 3 (
:w " >1 8 `OP "
2 , $
E $ ! / @# 9 +, d
(ADA)
~ $l
$C . N 5a >
s 0 g"=D b ! 2 ;
" :w [
# #
N 8$ C
" ? @# 8 " $ .
; Q 8 (
; A ; " 8 !
=1 ?$#
8 !
? @# SPSS
; D 8 ( 8
\ 0$0
N + . $ # / 6#
; ' # +0
"
.
# * +, - / L @
60
DKA = D
$
*
1$C $ .
/ / 6#
74 /
±11 62 / 26 F
# $1 / $ 7 )
50 (%
; $C 2
11 - 20 F . 36
$A#
)
60 (%
24
$A#
) 40 (%
$
# ) F Q
1 (.
$`" j $ # $1 / $ 7 # E 9 $M#
/ = ) 40 (%
g ! = / $
$( ~ !
? ) 7 / 1 (%
" b =C .
! 1 -
$ % &'(
) *+ , - . /
) / 0 1 ' / 2 3 % &'($
74 /
±11 63 /
26 / / 6#
24 /
36 ( /$){2Q
9 /
±3 2 /
7 ( )8$ < / 6#
3 /
±5 4 /
5 (F ) 5 N / 6#
) *+ , 1
/
±0 1 /
7 pH/ 6#
±239
605 (mg/dL) P 2 / 6#
5 /
±3 3 /
136 (mEq/L)3 / 6#
1 /
±12 8 /
102 (mEq/L)$> / 6#
7 / 16
% ( = D
&
# $1 / $ 7 2A ;
7 / 1
%
$ ; # $1 / $ ( = D
^ .
6#
8$ < / 9
/
±3 2 / 7 j $ # $1 / $ 7
N 8$ < N _2D
. 11
$A#
) 3 / 18 (%
/
>: o 5
2 " # . 7 / 41
%
> 1 1 0 5 r q l70 + F
" DKA
;
# . 3 / 83
% / , <#
7 / 16
%
.$O •$
# $ . E" / $ + "
W+*
, ) 50 (%
.
75 %
" ( b$ BD 15
% ,! y P &
7 / 6
%
D +*
3 / 3
%
# . 73
%
E,
! / 6# 2 "
mm3
±7704 15520 .
P 2 / 6#
mg/dL
±239 605
$ 7
) 7 / 21 (%
/ 2
mg/dL
700 - 800 2 "
. 75
%
F $# 3 25
% 2 " $0 # ] ( .
3 / 6#
mEq/L
5 /
±3 25 / 136 .
7 / 81
% , $#
3 / 3
% , ] ( 15
% , $] ( 2 "
.
pH/ 6#
q l70 1
/
±0 1 / 7
# $1 / $ 7
19 / 7 - 1 / 7
pH= )
F Q 1 (.
+ "
+ < 9 / $ ; 22
# A &
) 40 (%
# A L # / $ + "
UTI
# $1 45
% .
=
$ %$
$ / 5
%
#! ( `
# .
+(,
$* +, -
60
%
3 / [ #
Umpierrez +, - 66
% ) 5 (
Elisaf +, - ) 9 ( 53
%
$A# * +, - E (
80
% ) 10 (
; " b =C
[
$M#
i L " / 9 ,
# i
5 =
8
UTI # 2
9
; 22 <
" DKA
.
- 2 / 6#
&$* +, 74
/
±11 63 / 26 F
3 / [
Umpierrez +, - E (
) 8 ( 58
F } o 0
Elisaf
E ( 43
F ) 9 (
Flood +, - E (
7 / 10 F ) 11 (
; " b =C
c E# /
$( DKA
•2 f A0 # 0
1 .
; 2A j $ $* +, - # $1 / $ 7
$
$ # $1 / ;
. +* / Q 0 "
L " >
$ 7 p " < <A20 8 ` # A
$ 7 $
$C DKA
.
+, - / 8$ < N 2
/ 7
Umpierrez +, - E (
1 / 6 ) 5 ( +, -
Elisaf
k 1 ) 9 (
; " b =C [
/ "
5 : 1$C @ #
g k DKA
0 # # 8$ < A(
$M#
s $"
2" " q P$0 .
DKA L
L # $( M0 / , 2
1
DKA N
$* +, -
3 / 18
% +, -
Umpierrez
3 / 5
% ) 5 (
&
Elisaf +, - 6 / 30
% ) 9 (
&
+, - $A# * 6 / 16
% ) 10 (
Lee +, - 5 / 27
% ) 12 (
; " b =C .
$0 q l70 ? =, &; " $ | 8 ( !
@ 9:
7# DKA
( [ 8 a
Edge +, - ) 13 (
Flood +, - ) 11 (
" ; 7#
$0 q l70
$ %$
'(
( . W+* , E" / $ + " $* +, - ,
) 50 (%
[
$A# * +, - so1 )
10 ( 2 E" /
N +, - ; "
; 7# ; " , E" $6 .
$M#
345 $ , E"
DKA
$ ‚
g Q 2 <( O P
$1 g 5 2r
8 &
u E7 22 DKA
.
$ 7
2 <( " ( b$ BD DKA
[ 8 a
+, -
$*
75
%
; " $ N +, - # " (
; "
/ 8 ; 7# +*
.
} o 0 / 5
% 2 " \0 b$ BD
[
Elisaf +, - 10
%
; " $ | )
9 (.
E,
3 / 73
%
; ( 7
"
3 / [
Elisaf +, -
69 %
; " b =C )
9 (.
E,
72 a
; ( 7 DKA
7# "
DKA ; 2(
< # .
b$ BD , $ E, F5 P / $ + "
+, - /
$0 # ] (
3 / [
+, - 8
&
25
% b =C
; "
) 5 (.
5 / 81
%
& , $#
3 / 2
% , ] ( 15
%
2 " , $] ( N +, -
Umpierrez
) 8
Elisaf (
) 9 (
# l ( .
pH / 6#
/ } o 0 +, -
Elisaf
) 9
Flood ( ) 11 ( 15 / 7 0 1 / 7 7#
; 2(
"
DKA
ƒ5 # .
7 ~ $P ; " ql
pH =
r$( - b$ BD
/ D pH
$0
"
&
~ $P
( P $ 7 )
16&14 .(
> / $ + "
+, - DKA
$*
# A / [
= ) 40 (%
Umpierrez +, - 47
% ) 8 ( +, -
30 Lee
% ) 11 ( b =C
"
; . {D / , & # A
q l70 N / , <# .$O ? >
$ ( C! # A $
2 9>
8
@ 0
8$ C >Q DKA
$ .
8 # A ; " ? @# N +, - # A / $ + "
<A20 # A {]
; " b =C [
( 67 ! $
# A :2 $ D `Q
3` DKA
? @#
9 q l70 `Q 2 , g" \< $ N 7 ! $
g # A
; 22 .
#- . / +, - / _ # Q 0 3 < 2"! # $6# #
; P$ #
- DKA
E
8 ` 1
3`
>P \a
"
- b !
2 /
= # 0
$ %$ 5
( '(
$ • OP / [
`27 D
$C :
1 -
; 2( 7( 345 b !
DKA
2 - b ! 9
+ <
22
DKA ;
3 -
+ Q 3M2 3 <
0, 1 :
1- Larijani B, Zahei F. Epidemiology of diabetes mellitus in Iran. Iranian J Diabetes Lipid Disorders 2002; 1 (1): 1-8.
2- Chessler SD, Lernmark A. Type I (insulin- dependent). In: Davidson JK. Clinical Diabetes Mellitus: A Problem- oriented Approach. St.Louis: Thieme: 2000. pp: 37-58.
3- Becker KL, Bilezikian JP, Bremner WJ. Principles and Practice of Endocrinology and Metabolism. USA: Williams
& Wilkins; 2002.
4- Kitabchi AE. Acute Care of patients with diabetes. Diabetes Care. 2001; 24 (1): 31-33.
5- Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997; 157 (6): 69-75.
6- The DCCT Research Group: Implementation of treatment protocols in the Diabetes Control and Complications Trial Diabetes Care. 1995; 18 (3): 361-376.
7- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors . Harrison principles of Internal Medicine. 14th ed. New York: McGraw Hill, Health Profession Division; 1998.
8- Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;
2 (2): 95-108.
9- Elisaf MS, Tsatsoulis AA, Katopodis KP, Siamopoulos KC. Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. Diabetes Res Clin Pract. 1996; 34 (1): 23-27.
10- Rezvanfar MR. Evaluation of clinical manifestation, laboratory data and precipitating factors in patients with DKA hospitalized at Arak Valiasr hospital. Rah-Avard Quarterly J. 2001; 4 (4) 32-36.
11- Flood RG, Chiang VW. Rate and prediction of infection in children with diabetic ketoacidosis. Am J Emerg Med.
2001; 19 (4): 270-73.
12- Lee HK, Oh YS, Chung YH, Yoo HJ, Shin SH, Son HY, et al. Epidemiological characteristics of Ketoacidosis among Korean diabetic patients. J Korean Med Sci. 1987; 2 (1): 7-11.
13- Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999; 81 (4): 318-23.
14- Podar T, Solntsev A, Reunanen A, Urbonaite B, Zalinkevicius R, Karvonen M, et al. Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts. Care. 2000; 23 (3):
290-94.
15- Joudi B. Evaluation of relative frequency of laboratory data and result of therapy in patients with DKA in Alvin Qods hospital. [dissertation]. 2001.
16- Linares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy.
Pediatr Emerg Care. 1996; 12 (5): 347-51.
Title: Evaluation of clinical manifestation, laboratory data and precipitating factors in patients with Diabetic ketoacidosis in educational and medical care center of Booali Sina in Ghazvin (1999-2004)
Authors: Sheikholeslami H1, Ziaee A2, Shariatmadari M3 Abstract
Background and aim: Diabetic ketoacidosis is one of the major complications of diabetes whose due treatment can reduce its mortality. The aim of this study was to evaluate the clinical manifestation, laboratory data and precipitating factors in admitted patients to Booali hospital in Ghazvin.
Materials and Methods: In this descriptive retrospective study, all medical files of DKA patients between 1999 and 2004 in Ghazvin Booali hospital were surveyed. Totally, 60 episodes were evaluated with respect to clinical features, lab. findings and hospital mortality. Finally, the obtained data was statistically analyzed by means of SPSS software.
Results: Mean±SD age of patients was 26.63±11.74. Females and males were 60% and 40%, respectively.
Mean±SD hospitalization time was 7.2±3.9 days. DKA as the first symptom of diabetes occurred in 18.3% of clients. Feebleness and weakness were the most common complaint in 50% of patients, 75% were alert to their problem when hospitalized. Fever was detected in 50 %.The mean PH was 7.1±0.1. Hyponatremia occurred in 25%, urinary tract infection (UTI) in 54%, and hypoglycemia in 23% of the patients. During management, recurrent DKA was found in 3.3% and mortality rate was 5%.
Conclusion: Regarding the results of the study, which confirms lack of knowledge of the clinical staff as to how to confront and manage DKA-as a medical emergency due education in this field can reduce prevalence and mortality of DKA.
Key Words: Diabetes; Diabetes ketoacidosis; Hypoglycemia
1Corresponding author; Associate Professor, Department of Internal Medicine, Booali Hospital, Ghazvin University of Medical Sciences, Ghazvin, Iran. [email protected]
2Assistant Professor, Department of Internal Medicine, Booali Hospital, Ghazvin University of Medical Sciences, Ghazvin, Iran.
3Physician,Booali Hospital, Ghazvin University of Medical Sciences, Ghazvin, Iran
